A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
Clinical trial NCT07334483 · RECRUITING
Trial details
- NCT number
- NCT07334483
- Sponsor
- GrandPharma (China) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-22
- Primary completion
- 2027-12-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.